Capital Analysts, LLC First Trust Nyse Arca Biotechn Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Jan 30, 2024	SELL	$132.5 - $158.45 $13,250 - $15,844	-100 Reduced 6.04%	1,557 $246,000
Q3 2023 Nov 13, 2023	SELL	$145.69 - $157.89 $255,977 - $277,412	-1,757 Reduced 51.46%	1,657 $243,000
Q2 2023 Aug 11, 2023	SELL	$151.19 - $159.79 $7,559 - $7,989	-50 Reduced 1.44%	3,414 $523,000
Q1 2023 May 05, 2023	SELL	$147.92 - $165.37 $13,312 - $14,883	-90 Reduced 2.53%	3,464 $537,000
Q4 2022 Feb 08, 2023	SELL	$132.87 - $159.04 $23,783 - $28,468	-179 Reduced 4.8%	3,554 $548,000
Q3 2022 Nov 14, 2022	BUY	$128.6 - $149.75 $221,320 - $257,719	1,721 Added 85.54%	3,733 $493,000
Q2 2021 Nov 15, 2021	SELL	$157.67 - $176.2 $7,725 - $8,633	-49 Reduced 2.38%	2,012 $347,000
Q2 2021 Aug 05, 2021	SELL	$157.67 - $176.2 $679,715 - $759,598	-4,311 Reduced 67.66%	2,061 $356,000
Q1 2021 May 17, 2021	SELL	$156.06 - $184.84 $571,335 - $676,699	-3,661 Reduced 36.49%	6,372 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$152.75 - $174.52 $6,873 - $7,853	45 Added 0.45%	10,033 $1.69 Million
Q3 2020 Nov 12, 2020	BUY	$150.39 - $180.07 $49,327 - $59,062	328 Added 3.4%	9,988 $1.57 Million
Q2 2020 Aug 07, 2020	BUY	$127.11 - $171.8 $225,620 - $304,945	1,775 Added 22.51%	9,660 $1.62 Million
Q1 2020 May 08, 2020	BUY	$114.56 - $156.02 $896,775 - $1.22 Million	7,828 Added 13733.33%	7,885 $1.03 Million
Q4 2019 Feb 12, 2020	SELL	$120.34 - $154.01 $41,035 - $52,517	-341 Reduced 85.68%	57 $8,000
Q3 2019 Nov 12, 2019	BUY	$123.44 - $131.99 $7,036 - $7,523	57 Added 16.72%	398 $49,000
Q1 2019 May 13, 2019	BUY	N/A	341 New	341 $51,000

Others Institutions Holding FBT

# of Institutions

269

Shares Held

3.62M

Call Options Held

25.5K

Put Options Held

0

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.